Eric Van Ganse
- Fragmented care in asthma: Data from the French national claims databaseBy Laurent Laforest, Jennifer Martin, Idlir Licaj, Gilles Devouassoux, Gerard Chatte, Melanie Broquet and Eric Van GanseLaurent Laforest1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, FranceJennifer Martin1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, FranceIdlir Licaj1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, FranceGilles Devouassoux2Respiratory Medicine, Lyon-Sud University Hospital, Lyon, FranceGerard Chatte3Respiratory Physician, Respiratory Physician, Caluire, FranceMelanie Broquet1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, FranceEric Van Ganse1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, France
- Ratio “inhaled corticosteroids to total anti-asthma drugs”, and asthma-related hospital admissionsBy Laurent Laforest, Jennifer Martin, Idlir Licaj, Gilles Devouassoux, Gerard Chatte and Eric Van GanseLaurent Laforest1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, FranceJennifer Martin1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, FranceIdlir Licaj1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, FranceGilles Devouassoux2Respiratory Medicine, Lyon Sud University Hospital, Lyon, FranceGerard Chatte3Respiratory Physician, Respiratory Physician, Caluire, FranceEric Van Ganse1Unité de Pharmacoépidémiologie, 11 rue Guillaume Paradin, Lyon University Hospital, Claude-Bernard Lyon1 University, Lyon, France
- Correlates of high levels of use of short-acting beta agonists in asthmaBy Laurent Laforest, Jennifer Martin, Idlir Licaj, Gilles Devouassoux, Gérard Chatte, Mélanie Broquet and Eric Van GanseLaurent Laforest1Unité de Pharmacoépidémiologie, Université Claude-Bernard Lyon1, CHU Lyon-Université Claude-Bernard Lyon1, Lyon, FranceJennifer Martin1Unité de Pharmacoépidémiologie, Université Claude-Bernard Lyon1, CHU Lyon-Université Claude-Bernard Lyon1, Lyon, FranceIdlir Licaj1Unité de Pharmacoépidémiologie, Université Claude-Bernard Lyon1, CHU Lyon-Université Claude-Bernard Lyon1, Lyon, FranceGilles Devouassoux2Respiratory Medicine, Lyon Sud University Hospital, Pierre Benite, FranceGérard Chatte3Respiratory Physician, Respiratory Physician, Caluire, FranceMélanie Broquet1Unité de Pharmacoépidémiologie, Université Claude-Bernard Lyon1, CHU Lyon-Université Claude-Bernard Lyon1, Lyon, FranceEric Van Ganse1Unité de Pharmacoépidémiologie, Université Claude-Bernard Lyon1, CHU Lyon-Université Claude-Bernard Lyon1, Lyon, France
- Asthma drug ratios and exacerbations: claims data from universal health coverage systemsBy Laurent Laforest, Idlir Licaj, Gilles Devouassoux, Gérard Chatte, Jennifer Martin and Eric Van GanseLaurent Laforest1Unité de Pharmacoépidémiologie, CHU-Lyon, Faculté d’Odontologie, UMR 5558-LBBE, CNRS, Université Claude Bernard, LyonIdlir Licaj1Unité de Pharmacoépidémiologie, CHU-Lyon, Faculté d’Odontologie, UMR 5558-LBBE, CNRS, Université Claude Bernard, LyonGilles Devouassoux2Service de Pneumologie, Hôpital de la Croix Rousse, Hospices Civils de Lyon, LyonGérard Chatte3Liberal Chest Physician, Caluire, FranceJennifer Martin1Unité de Pharmacoépidémiologie, CHU-Lyon, Faculté d’Odontologie, UMR 5558-LBBE, CNRS, Université Claude Bernard, LyonEric Van Ganse1Unité de Pharmacoépidémiologie, CHU-Lyon, Faculté d’Odontologie, UMR 5558-LBBE, CNRS, Université Claude Bernard, Lyon2Service de Pneumologie, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon
- Relative exposure to inhaled steroids (ratio "ICS-to-total asthma therapy"): Concordant data from electronic medical records, claims data and patient-reported outcomesBy Laurent Laforest, Idlir Licaj, Gilles Devouassoux, Genevieve Chamba, Laurent Letrilliart, Gerard Chatte and Eric Van GanseLaurent Laforest1Pharmacoepidemiology, CHU Lyon; UMR 5558 CNRS - Claude Bernard University, Lyon, FranceIdlir Licaj1Pharmacoepidemiology, CHU Lyon; UMR 5558 CNRS - Claude Bernard University, Lyon, FranceGilles Devouassoux2Respiratory Medicine, Croix Rousse University Hospital, Lyon, FranceGenevieve Chamba3Pharmakeion, Pharmakeion, Lyon, FranceLaurent Letrilliart4Department of General Practice, Claude Bernard University, Lyon, FranceGerard Chatte5Chest Physician, Caluire, FranceEric Van Ganse1Pharmacoepidemiology, CHU Lyon; UMR 5558 CNRS - Claude Bernard University, Lyon, France2Respiratory Medicine, Croix Rousse University Hospital, Lyon, France
- Prescription of antitussives in asthma: A cross-sectional study in primary care in France and in ItalyBy David Darmon, Laurent Laforest, Eric Van Ganse, Gilles Devouassoux, Alain Follet and Laurent LetrilliartDavid Darmon1Department of Education and Research in General Practice, University of Nice Sophia-Antipolis, Nice, FranceLaurent Laforest2Pharmacoépidémiology Unit, CHU-Lyon, UMR 5558 CNRS - Claude-Bernard University, Lyon, FranceEric Van Ganse2Pharmacoépidémiology Unit, CHU-Lyon, UMR 5558 CNRS - Claude-Bernard University, Lyon, France3Respiratory Medicine, Croix-Rousse Hospital, Lyon, FranceGilles Devouassoux3Respiratory Medicine, Croix-Rousse Hospital, Lyon, FranceAlain Follet2Pharmacoépidémiology Unit, CHU-Lyon, UMR 5558 CNRS - Claude-Bernard University, Lyon, FranceLaurent Letrilliart4Department of General Practice, Claude Bernard University, Lyon, France
- Factor associated with global mortality in COPD between 2006 and 2011: French claims dataBy Laurent Laforest, Cheikh Tamberou, Marine Ginoux, Chu-Philippe Ya, Gilles Devouassoux, Nicolas Roche, Christos Chouaid and Eric Van GanseLaurent Laforest1Pharmacoépidemiology, Lyon University Hospital UMR 5558 CNRS - Claude Bernard University, Lyon, FranceCheikh Tamberou1Pharmacoépidemiology, Lyon University Hospital UMR 5558 CNRS - Claude Bernard University, Lyon, FranceMarine Ginoux1Pharmacoépidemiology, Lyon University Hospital UMR 5558 CNRS - Claude Bernard University, Lyon, FranceChu-Philippe Ya1Pharmacoépidemiology, Lyon University Hospital UMR 5558 CNRS - Claude Bernard University, Lyon, FranceGilles Devouassoux2Respiratory Medicine, Croix-Rousse University Hospital, Lyon, FranceNicolas Roche3Respiratory and Intensive Care Medicine & University Paris Descartes, Hôtel-Dieu Hospital, Paris, FranceChristos Chouaid4Respiratory Medicine, Creteil University Hospital, Creteil, FranceEric Van Ganse1Pharmacoépidemiology, Lyon University Hospital UMR 5558 CNRS - Claude Bernard University, Lyon, France2Respiratory Medicine, Croix-Rousse University Hospital, Lyon, France
- Effectiveness of montelukast on asthma control in infants: A claims data studyBy Manon Belhassen, Marine Ginoux, Valérie Laigle, Céline Chanut-Vogel, Liliane Lamezec, Jacques De Blic, Jacques Brouard, Brigitte Fauroux, Gérard De Pouvourville, Laurent Laforest and Eric Van GanseManon Belhassen1Lyon Pharmacoepidemiology Unit, University of Lyon, Lyon, FranceMarine Ginoux1Lyon Pharmacoepidemiology Unit, University of Lyon, Lyon, FranceValérie Laigle2Market Access, MSD France, Courbevoie, FranceCéline Chanut-Vogel2Market Access, MSD France, Courbevoie, FranceLiliane Lamezec2Market Access, MSD France, Courbevoie, FranceJacques De Blic3Pediatric Medicine, Necker University Hospital, Paris, FranceJacques Brouard4Pediatric Medicine, University Hospital, Caen, FranceBrigitte Fauroux5Pediatric Medicine, Trousseau University Hospital, Paris, FranceGérard De Pouvourville6ESSEC, ESSEC, Paris, FranceLaurent Laforest1Lyon Pharmacoepidemiology Unit, University of Lyon, Lyon, FranceEric Van Ganse1Lyon Pharmacoepidemiology Unit, University of Lyon, Lyon, France
- Asthma management in French general practice: Physician-reported medical care and adherence supportBy Alexandra Lelia Dima, Eric Van Ganse, Helene Le Cloarec and Marijn De BruinAlexandra Lelia Dima1Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, NetherlandsEric Van Ganse2Pharmaco-Epidemiology Unit, University Claude Bernard Lyon 1, Lyon, France3Respiratory Medicine, Croix-Rousse University Hospital, Lyon, FranceHelene Le Cloarec4Pharmacoepidemiology, Kappa Santé, Paris, FranceMarijn De Bruin1Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, Netherlands5Aberdeen Health Psychology Group, University of Aberdeen, Aberdeen, United Kingdom
- Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohortBy Eric Van Ganse, Laurent Laforest, Hélène Le Cloarec and Alexandra DimaEric Van Ganse1Lyon Pharmacoepidemiology Unit, Lyon University Hospital UMR 5558 CNRS - Claude Bernard University, Lyon, France2Respiratory Medicine, Croix-Rousse University Hospital, Lyon, FranceLaurent Laforest1Lyon Pharmacoepidemiology Unit, Lyon University Hospital UMR 5558 CNRS - Claude Bernard University, Lyon, FranceHélène Le Cloarec3Kappa Santé, Paris, FranceAlexandra Dima4Amsterdam School of Communication Research ASCoR, University of Amsterdam, Amsterdam, Netherlands
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.